ASCO Abstract Highlights Growing Comfortability with Trastuzumab Biosimilars.

THERAPEUTIC use of antineoplastic agents; ABSTRACTING; MEETINGS; BODY weight; HEALTH services accessibility; TRASTUZUMAB; HUMAN comfort; BIOSIMILARS; INTERVIEWING; MEDICAL care costs; MARKETING; SURVEYS; COMPARATIVE studies; AMERICAN Society of Clinical Oncology; BREAST tumors; PSYCHOLOGY of physicians; COVID-19 pandemic; ONCOLOGISTS

The article focuses on the growing utilization of trastuzumab biosimilars in India, as highlighted in an American Society of Clinical Oncology (ASCO 2023) abstract. Topics discussed include trends in physician use of trastuzumab, significant increase in biosimilar utilization over seven years, and the preference for biosimilars due to affordability and accessibility.